BSX.PRA

Barclays’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-848	Closed	-$103K	–	4579
2023 Q1	$103K	Sell	848 -17,674	-95%	-$2.15M	﹤0.01%	3513
2022 Q4	$2.13M	Buy	18,522 +10,900	+143%	+$1.25M	﹤0.01%	1611
2022 Q3	$771K	Buy	+7,622	New	+$771K	﹤0.01%	2300